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Abstract
Background: We aimed to overview the current literature on eurythmy therapy (EYT) which is
an integral part of Anthroposophic Medicine. EYT can be described as a movement therapy in
which speech movements are transposed into exercises which address the patient's capability to
soul expression and strengthen his salutogenetic resources.
Methods: We searched several databases such as Cochrane, EMBASE, NCCAM, NLM, DIMDI,
CAMbase, and Medline for case-control studies, cohort studies and randomised controlled trials
on the treatment effects of EYT in a clinical setting. In a second search we included journal
databases from Karger, Kluwer, Springer, Thieme, and Merkurstab archive.
Results: We found 8 citations which met the inclusion criterion: 4 publications referring to a
prospective cohort study without control group (the AMOS study), and 4 articles referring to 2
explorative pre-post studies without control group, 1 prospective, non-randomized comparative
study, and 1 descriptive study with a control group. The methodological quality of studies ranged
in from poor to good, and in sample size from 5 to 898 patients. In most studies, EYT was used as
an add-on, not as a mono-therapy. The studies described positive treatment effects with clinically
relevant effect sizes in most cases.
Conclusion: Indications, study designs and the usage of additional treatments within the identified
studies were quite heterogeneous. Despite of this, EYT can be regarded as a potentially relevant
add-on in a therapeutic concept, although its specific relevance remains to be clarified. Well
performed controlled studies on this unique treatment are highly recommended.
Background
Complementary and alternative medicine (CAM) has
become increasingly popular over the last decades.
According to Bausell et al. [1], especially patients with
chronic diseases increasingly seek for CAM-therapies.
With a growing amount of health information in the
internet, physicians and therapists and patients are often
not prepared to judge provided information of CAM-
health care approaches properly. Information dissemina-
tion of published evidence about the effectiveness of rem-
edies and therapies therefore forms a neccesary basis for
shared-decision making for patients and practitioners.
While scientific evidence exists for some popular CAM
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therapies like acupuncture [2,3], well-designed scientific
studies are lacking for most other CAM therapies.
One popular representative of the so called "Whole Med-
ical Systems" with a complete system of theory and prac-
tice with a distinct usage of mind-body based approaches
is Anthroposophic Medicine (AM). It was founded in the
1920s by the Austrian philosopher Rudolf Steiner and the
Dutch physician Ita Wegman [4], and can be regarded as
a complete medical system of theory and practice, with a
distinct usage of mind-body based practices. The core con-
cepts are that the body is not an independent material
organism, and that health depends on a harmonious rela-
tionship between the physical body, vital force, soul, and
ego. AM therefore intends to address the salutogenetic
capacities of the patients, and to strengthen their auton-
omy [5]. For each patient, AM oriented physicians and
therapists develop individual therapeutic strategies which
– apart from conventional treatments – include Art Ther-
apy (i.e. painting, drawing, clay modelling, music or
speech exercises), Rhythmical Massage, Eurythmy Ther-
apy (EYT), Counselling, and AM medication of mineral,
botanical or zoological origin (mostly used in homeo-
pathic dilutions). Because of this unique and individual-
ized approach, only a few studies within this framework
follow the conventional methodological conventions.
Much is known about the AM-based application of mistle-
toe extract in cancer patients [6-8], and a recent Health
Technology Assessment by Kienle et al. [9] reviewed the
effectiveness, benefit, efficiency and safety of AM. Because
of the outstanding importance in AM based treatment of
patients and some impressive (anecdotic) case reports, we
intended to overview the current literature on the clinical
effects of EYT.
EYT ("harmonious rhythm"), introduced by Rudolf
Steiner in 1911, can be described as an active exercise ther-
apy, involving cognitive, emotional and volitional ele-
ments [10]. Although there are some similarities with
(psychotherapeutic) dance therapy, EYT is a unique move-
ment therapy in which speech movements are transposed
into exercises which address the patient's capability to
soul expression and strengthen his salutogenetic
resources. These specific body movements go along with
meditative aspects in terms of guided imagery. EYT is
assumed to have general effects (i.e. improving breathing
patterns and posture, strengthening muscle tone, enhanc-
ing physical vitality [5]), and specific therapeutic effects.
Moreover, EYT claims to stimulate somatic healing proc-
esses through the soulful experience of the respective
movements [11].
Methods
We intended to search for English or German language
cohort studies and controlled trials which address the spe-
cific treatment effects of EYT in a clinical setting (inclusion
criterion). Comments, opinions, and theoretical consider-
ations were excluded. As broad search terms we used the
most global term "eurythmy", and its German translation
"Eurythmie" and its modification "Heileurythmie".
To get a first overview, the following electronical data-
bases were used to find articles: MEDLINE, EMBASE, The
Cochrane database, DIMDI and CAMbase. Finally, we
also screened the journal databases of Karger, Kluwer,
Springer, Thieme and the Merkurstab archive to find rele-
vant information. In addition, an internet search was per-
formed using Google Scholar adding the search terms
"study" to the above search terms.
The complete search was performed in June and October
2007.
All articles found this way were fully read and their refer-
ence lists were checked for further relevant publications.
Moreover, we contacted experts in the field of AM to find
other relevant studies.
We graded the methodological quality of the studies by
the following checklist: Adequate description of the sub-
ject assembly process (methods for patient selection
described, eligible but not enrolled subjects and reason
for exclusion), equality of comparison groups in the case
of controlled studies, adequate description of subject fol-
low up, adequate description of treatment, unbiased sur-
veillance for adverse outcomes. The quality details of the
relevant studies are discussed in the description of studies.
The reporting of the results adhered, if possible and
appropriate, to the MOOSE guidelines [12].
However, as the studies were quite heterogeneous includ-
ing a variety of perspectives, but not any randomised con-
trolled trial, we decided to classify them roughly at first
glance with respect to indication, treatment setting,
research design, the number of patients involved and the
outcome measures/results given in the studies/reports.
Where possible, we calculated an effect size (Cohen's d) or
indicated at least Standardised Response Means (= mean
change score divided by the standard deviation of the
change score). According to Cohen [13] and Wolff [14],
we judged effect sizes > 0.8 as indicators of large effects,
and 0.5–0.8 for moderate effects. We judged effect sizes >
1.0 as relevant, which – according to Cohen [13] – indi-
cate a non-overlap of > 55% in the two distributions.BMC Complementary and Alternative Medicine 2008, 8:8 http://www.biomedcentral.com/1472-6882/8/8
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Results
Search results
The DIMDI database revealed 18 hits for the term
"eurythmy": 8 were duplicates, and 10 were identified as
independent contributions (Table 1). However, some ref-
erences had to be excluded because the term eurythmy
was used in an another context, one was a German lan-
guage interview on the students of Waldorf schools, and
one was a German language comment by Ernst [15] on a
clinical study by Majorek et al. [10]. One paper of Hamre
et al. [16] focused on health costs in anthroposophic ther-
apy users, and a study by Heusser et al. [17] addressed
treatment pattern and compliance with AM, and thus
both were excluded too.
Because the founding papers on eurythmy were in Ger-
man language, we sought German language articles by
performing a search in the database CAMbase and the
archive of the journal "Der Merkurstab" (from 1946 to
2007). Within the "Merkurstab" archive we found 92 con-
tributions referring to the term "Heileurythmie", while
the adjective "heileurythmisch" appeared in 14 references.
Most were theoretical reflections, announcements or
reports of courses. Nevertheless, in this second run we
found several German language case-reports (most of
them were anecdotic if anything, or had a focus on the
description of exercises rather than on the clinical out-
come) and 2 additional studies. Because one can not
exclude a publication bias among the case reports, which
predominantly described beneficial effects, and only a few
no significant clinical changes at all, they could be evalu-
ated in a separate paper.
Although we found some other articles mentioning the
usage of EYT within in a complex therapeutic setting (i.e.
[17-22]), they were not included in this review, because
our main intention was to focus on clinical trials which
addressed the specific effects of EYT. Nevertheless, we
diverged from this inclusion criterion only in case of the
Anthroposophic Medicine Outcome Study (AMOS),
which was published with respect to different details [23-
26], but has to be regarded as one study, and described the
number of patients with EYT usage.
Description of studies
The search strategy identified 8 reports which met the
inclusion criterion. With respect to the design, we had 4
publications referring to a prospective cohort study with-
out control group (the AMOS study, which investigated
the effectiveness and costs of AM therapies in outpatients
with chronic disease), and 4 articles referring to 2 explor-
ative pre-post studies without control group, 1 prospec-
tive, non-randomized comparative study, and 1
descriptive study with a control group (Table 2).
The methodological quality of studies ranged from poor
to good, and in sample size from 5 to 898 patients. The
study of Hamre and co-workers [23-26] analysed patients
with various chronic diseases (i.e. mental, respiratory,
musculoskeletal, etc.), while the others investigated
patients with heart attack, anorexia nervosa, depression,
chronic low back pain, and attention deficit hyperactive
disorder (ADHD), respectively.
In the identified pre-post studies, the description of
enrolled patients and their diagnoses was fulfilled par-
Table 1: Citations of the term eurythmy found in the databases and their source
Found in the first run of the search:
1) Majorek et al., 2004: Therapeutic Eurythmy-movement therapy for children with attention deficit hyperactivity disorder (ADHD): a pilot study. 
MEDLINE
2) Hamre et al., 2004: Anthroposophic therapies in chronic disease: the Anthroposophic Medicine Outcomes Study (AMOS). MEDLINE
3) Hamre et al., 2006a: Anthroposophic therapy for chronic depression: a four-year prospective cohort study. MEDLINE
4) Hamre et al., 2007a: Eurythmy therapy in chronic disease: a four-year prospective cohort study. MEDLINE
5) Hamre et al. 2007b: Anthroposophic medical therapy in chronic disease: a four-year prospective cohort study. MEDLINE
6) Hamre et al., 2007c: Anthroposophic vs. conventional therapy for chronic low back pain: A prospective comparative study. EMBASE
* Ernst, 2004: Eurythmie beruhigt den Zappelphilipp. MEDLINE
* Hamre et al., 2006b: Health costs in anthroposophic therapy users: a two-year prospective cohort study. MEDLINE
* Heusser et al., 2006: Palliative in-patient cancer treatment in an anthroposophic hospital: I. Treatment patterns and compliance with 
anthroposophic medicine. MEDLINE
* Interview: Waldorfschulen – Selbstbewusst ins Leben, Deutsches Ärzteblatt
* Characteristics of lumbar segment injury of spinal cord in eurythmics athletes. EMBASE
Found in the Second run of the search:
7) Fischer K, Rheingans, 1985: Vergleichende Untersuchung einer künstlerisch-übenden mit einer konventionell aktiv-trainierenden Kurbehandlung 
an Herz- und Kreislaufkranken mit einer Herzinfarktgruppe. ERFAHRUNGSHEILKUNDE
8) Bräuner-Gülow and Gülow, 2006: Heileurythmie bei Magersucht im Jugendalter. Methodik zur Bewegungsanalyse. Aspekte zur Diagnostik, 
Bewegungstherapie und Forschungsstand. Zusammenfassung einer Pilotstudie von 2002–2005. Der Merkurstab
* not in accordance with criteriaBMC Complementary and Alternative Medicine 2008, 8:8 http://www.biomedcentral.com/1472-6882/8/8
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tially. Particularly the well designed AMOS study [23-27]
enrolled a quite heterogeneous cohort of patients – albeit
this may reflect the "real life" situation in most medical
wards.
The criteria for selection of patients in the study of
Majorek et al. [10] are unclear. In the study of Fischer and
Rheingans [28], which described the results quite well,
one can not ignore potential bias problems, and poorly
defined primary aims; moreover, because all patients were
in a health resort for several months, one may expect a
spontaneous improvement of the clinical situation any-
way.
The exploratory pre-post study of Bräuner-Gülow and
Gülow [29] had a good description of the EYT related
diagnostic criteria and identified types, and the EYT
effects, but lacks a control group.
In most studies, EYT was used as an add-on, not as a
mono-therapy. Just one study [10] explicitly investigated
the effects of EYT in 5 ADHD boys, which did not receive
additional medication (just one with additional methyl-
phenidate medication). The evaluations of Hamre's group
[23-27] described the outcome effects of a "therapy pack-
age", which included EYT and other medications.
Therapeutic Effects
First we analyzed the prospective AMOS cohort study
[23,25,26] with a pre-post design but without a control
group (Tables 2 and 3). This study was a 4-year prospec-
tive cohort study and referred to patients with various
chronic diseases such as mental, respiratory, musculoskel-
etal, headache etc. One evaluation [25] specifically
addressed the effects of EYT which was used in 94%,
adjunctive AM medication in 75%, and other treatments
(but 63% of patients were without diagnosis-related
adjunctive therapy). As shown in Table 3 and Figure 1, the
authors reported significant improvement of disease and
symptom scores (effect sizes for 0–12 months compari-
son: 1.34 and 1.04; Cohens'd indicate large effects with
respect to both variables) and quality of life (SF-36 Health
Change for Adults, and KITA Psychosoma and Daily Life
subscales for children: 0.41–0.67), but also a slight
increase of psychotherapy usage. All other published clin-
ical outcome details of the AMOS study were summarized
in Tables 2 and 3.
It is worth to mention that adverse reactions to EYT
occurred just in 3% (3/419) of patients, but none stopped
EYT due to the adverse reactions [25]. The authors men-
tioned the absence of a comparison group receiving
another treatment or no therapy, but countered that "non-
AM adjunctive therapies cannot explain the improvement
of Disease and Symptom scores, since the improvements
were even more pronounced in patients nut using such
therapies".
Next we analyzed the two exploratory pre-post studies
without a control group (Tables 2 and 3). The study by
Bräuner-Gülow and Gülow [29] investigated 70 girls
respectively women with Anorexia nervosa, which
received EYT, psychotherapy, change of eating habits, art
therapy, and patient caring procedures. None of them
required artificial feeding at the end of the hospital stay.
The authors reported an improvement of cold of limbs
Table 2: Design of clinical studies enrolling therapeutic eurythmy (with and without add-on treatments)
Reference Indication Research design Number of patients Durationof study
Fischer and Rheingans, 
1985
heart attack prospective study with control 
group
39 (23 + 16) patients in a 
health resort
7 month
Majorek et al., 2004 attention deficit hyperactive 
disorder (ADHD)
exploratory pre-post case study 
without control group
5 boys (8–10 years) 9 month
Bräuner-Gülow and 
Gülow, 2006
anorexia nervosa exploratory pre-post study 
without control group
70 girls/women (10–19 
years)
4 years
Hamre et al., 2004 various chronic diseases (mental, 
respiratory, musculoskeletal, 
etc.)
prospective cohort study (pre-
post design without control 
group (AMOS)
898 outpatients 4 years
Hamre et al., 2006a depression prospective cohort study (pre-
post design) without control 
group (AMOS)
97 outpatients 4 years
Hamre et al., 2007a various chronic diseases (mental, 
respiratory, musculoskeletal, 
headache etc.)
prospective cohort study (pre-
post design without control 
group (AMOS)
419 outpatients 4 years
Hamre et al., 2007b various chronic diseases (mental, 
respiratory, musculoskeletal, 
headache etc.)
prospective cohort study (pre-
post design without control 
group (AMOS)
233 outpatients 4 years
Hamre et al., 2007c Chronic low back pain prospective non-randomized 
comparative study (AMOS)
62 (34 + 28) patients 1 yearBMC Complementary and Alternative Medicine 2008, 8:8 http://www.biomedcentral.com/1472-6882/8/8
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(55/67) and constipation (38/54), but no changes in
amenorrhea. Moreover, the therapists reported improve-
ment of fluent movements, decrease of movement com-
pulsion etc.; and improvement of body perception. The
body mass index of the girls improved, particularly in the
younger girls: effect size 10–13 year old girls pre-post:
0.79, and in 14–16 year old girls 1.08, but not in 17–19
year old girls (effect sizes pre-post: 0.23). Cohen's d indi-
cate large effects for the younger girls, and small effects for
the older girls (Table 3; Figure 1).
The exploratory pre-post case study without control group
by Majorek et al. [10] investigated the effect of EYT in 5
boys with attention deficit hyperactive disorder (ADHD).
Effect sizes (Cohen's d) of studies on EYT Figure 1
Effect sizes (Cohen's d) of studies on EYT. Analysed variables of the respective studies were indicated. Effect sizes were 
classified as small (0.20–0.49), medium (0.50–0.79), and large (≥ 0.80).BMC Complementary and Alternative Medicine 2008, 8:8 http://www.biomedcentral.com/1472-6882/8/8
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Just one of them received additionally methylphenidate.
The authors reported positive changes in movement skills
and concentration, minor improvement on working
speed, slight improvement of social behaviour problems
and slight drop of hyperactivity (Table 3).
Two studies had a control group or a comparison design
(Tables 2 and 3). The study with a prospective non-rand-
omized comparison design which is part of the AMOS
study [27] enrolled patients with chronic low back pain
(Table 3). It revealed significant improvement of symp-
tom scores (calculated effect sizes for 0–12 months com-
parison: 1.0 in AM vs. 0.5 in control; as shown in Table 3
and Figure 1, Cohen's d indicate large effects for AM group
and moderate effect for conventional group) and physical
health (SF-36 effect size: -0.8 in AM vs. -0.2 in control) in
both groups, while in the AM group more pronounced
improvements for mental health, general health and vital-
ity were observed. With 34 patients in the AM group
(enrolled by 25 physicians), and 28 patients in the con-
ventionally treated group (enrolled by 13 physicians), the
sample size of the study was low.
The other study with a controlled design investigated 39
patients in a health resort and a complex therapeutic
approach [28]. The authors measured blood pressure,
physical capacity and several other physiological parame-
ters. Although both groups were not recruited at the same
time, the treatment effects were similar in both groups,
EYT and physical training respectively. Several positive
effects, particularly psycho-mental strains, were stronger
in the EYT group. However, the statistical analyses were
pre-post analyses of the respective group, and did not test
between the groups. The overall results of the study reflect
an effective stay at a health resort with intended normali-
zation of blood pressure and other parameters.
Discussion
Indications, study designs, outcome parameters and the
usage of additional treatments within the few identified
studies enrolling EYT were quite heterogeneous. Because
non-pharmacological interventions in CAM such as EYT
do not receive relevant financial support, well designed
controlled studies are rare. Nevertheless, some of the stud-
ies reported here had a satisfactory quality and an appro-
priate data presentation. In contrast, the retrieved German
language case-reports had several methodological flaws
and obscurities, one can not exclude a positive publica-
tion bias, and thus they can not be regarded as a valid
ground to approve the clinical effects of EYT. A possible
Table 3: Clinical studies enrolling therapeutic eurythmy (with and without add-on treatments)
Ref. Treatment Results Effect size (Cohen's d)
[28] EYT; additionally: CO2 bathes, swimming, massages, 
inhalations, diet, health related lectures
Physiological and psychomental reactions similar to control group with active 
training, particularly psychomental strain and others better in the EYT group
/
[10] EYT, 30 min. once a week (7 – 25 sessions per child); no 
other therapy during study, but 1 child with 
methylphenidate medication
Positive changes (normalisation) of movement skills (5/5) and concentration 
(4/5); minor improvement on working speed (5/5); slight improvement of 
social behaviour problems (4/5) and slight drop of hyperactivity (4/5); stopping 
of methylphenidate medication at the end of the study in 1/1
/
[29] EYT, 25 min. 3–5x per week, 6–14 weeks treatment 
period during hospital stay; additional treatments: 
psychotherapy, change of eating habits, art therapy, 
patient caring procedures
Improvement of Body Mass Index in 10–13 year old girls (pre-post 
Standardised Response Mean: 0.79), in 14–16 year old girls (pre-post 
Standardised Response Mean: 1.08), but not in 17–19 year old girls (pre-post 
Standardised Response Mean: 0.23); improvement of cold of limbs (55/67) and 
constipation (38/54); artificial feeding not required any longer (0/54); no 
changes in amenorrhea (53/53); improvement of fluent movements, decrease 
of movement compulsion etc.; improvement of body perception
10–13 years: 1.02 
(0.26–2.45; large effect); 
14–16 years: 0.99 
(0.31–1.57; large effect); 
17–19 years: 0.22 (-
1.00–1.32; small effect)
[23] EYT (47%), AM art therapy (18%), rhythmic massage 
(10%), AM medication (26%); median therapy duration 
120 days (interquartile range 81–195); median number 
of therapy sessions 12 (interquartile range 10–20)
Significant improvement of disease and symptom scores (Standardised 
Response Mean for 0–6 months: 1.23 and 1.09), and quality of life (SF-36, 
KINDL and KITA)
[24] AM medication (13%) and AM therapies (87%), such as 
art therapy (43%), EYT (37%), rhythmical massage 
therapy (6%); median therapy duration 137 days 
(interquartile range 91–212); 29% used antidepressants 
within the first 6 study months, 24% had at least 10 
psychotherapy sessions, 55% had no standard therapy 
(i.e. psychotherapy, antidepressants)
Significant improvement of depression (CES-D: Standardised Response Mean 
for 0–12 months: 1.20 [art therapy 1.32, painting, drawing, clawing 1.25, EYT 
1.08]), disease and symptom scores (1.77 and 0.91), and quality of life (SF-36 
mental: 1.11)
[25] EYT (94%) with a median therapy duration 119 days 
(interquartile range 84–188), median number of therapy 
sessions 12 (interquartile range 10–19); adjunctive AM 
medication in 75%; other treatments were used too (but 
63% of patients were without diagnosis-related 
adjunctive therapy)
Significant improvement of disease and symptom scores (Standardised 
Response Mean for 0–12 months comparison: 1.34 and 1.04) and quality of life 
(SF-36 and KITA: 0.41–0.67);; significant increase of psychotherapy usage
disease score: 1.70 (1.47 
– 1.99; large effect); 
symptom score: 1.27 
(1.08–1.50; large effect)
[26] AM medication (71–86%), AM art therapy (4%) and EYT 
(14%); other treatments were used too (but 63% of 
patients were without diagnosis-related adjunctive 
therapy)
Significant improvement of disease and symptom scores (Standardised 
Response Mean for 0–12 months comparison: 1.52 and 1.04, and quality of life 
(SF-36 and KITA: 0.33–0.71); Significant increase of AM medication and 
psychotherapy usage
[27] AM therapy (incl. 70% EYT, 24% rhythmical massage, 6% 
art) versus conventional therapies
Significant improvement of symptom scores (pre-post Standardised Response 
Mean for 0–12 months comparison: 1.0 in AM vs. 0.5 in control) and physical 
health score (SF-36 Standardised Response Mean: -0.8 in AM vs. -0.2 in 
control) in both groups; after adjustment, in AM group more pronounced 
improvements for mental health, general health and vitality
symptom score 
conventional group: 0.57 
(0.02 – 1.31; moderate 
effect), AM group: 1.00 
(0.33–1.67; large effect)BMC Complementary and Alternative Medicine 2008, 8:8 http://www.biomedcentral.com/1472-6882/8/8
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bias factor which is difficult to exclude could be the spe-
cific AM background of the research groups and thera-
pists; however, one may assume this bias in most articles
on unique CAM remedies. Hamre et al. [25] and Kienle et
al. [9] analysed several potential bias factors in EYT and
AM and performed sensitivity analyses, which all indi-
cated validity of published data.
Nevertheless, the retrieved clinical studies describe signif-
icant improvements of the symptoms, which can be
ascribed to effects of the multimodal treatment
approaches of AM. In the study of Majorek et al. [10], one
has to state impressive treatment effects of EYT, which was
used as the sole therapy in 4/5 boys. In all other studies,
one may assume that EYT at least has contributed signifi-
cantly to the positive effects – without any relevant side
effects. It is difficult to judge the unique contributions of
the different AM therapies used as a "therapy package".
From a therapeutic point of view this is a comprehensible
necessity to address different "aspects" of a patient, but
from an analytical point of view one would rather investi-
gate the effects of the constituents of this "therapy pack-
age".
In fact, Hamre and co-workers stated that AM therapies
"were evaluated as a therapy package, the question of spe-
cific therapy effects vs. non-specific effects (placebo
effects, context effects, patient expectations etc.) was not
an issue of the present analysis" [24]. Although in the pro-
spective cohort studies of Hamre et al. [24,26], the impact
of EYT was somewhat lower than that of other AM thera-
pies, they were nevertheless effective – and addressed
other relevant aspects of the patients, which contributed
to a process of healthy improvement.
From a theoretical point of view there is a sound rationale
to apply EYT in patients [11,30], while the empirical evi-
dence for its essential use is unclear. The most common
diagnoses in Hamre's studies ranged from "severe" to
"moderate", i.e. malignancies, mental/mood disorders,
neck-shoulder-arm pain, back pain, headache/migraine,
asthma, sinusitis, fatigue, and other diagnoses [23-26].
Although one may assume that some of these diseases
may improve in response towards a therapeutic interven-
tion and during time anyway, more than 95% of these
patients had median disease duration of 3 years (IQR 0.5
– 9.8 and 1.0 – 8.5, respectively), and thus a suggested
"spontaneous recovery" of symptoms with the onset of
AM interventions in all cases is implausible. Nevertheless,
without disease related cohorts or a control group, which
is lacking in most of the studies, it is difficult to substanti-
ate the assumed effectiveness of the therapeutic strategies,
particularly EYT. However, Hamre et al. [25] performed
two bias analyses, first a dropout bias analysis (which
reducing the average 0–12 months improvements by 19%
and 4%, respectively), and the second addressing the
effects of relevant adjunctive therapies. It was mentioned
that restricting the sample to patients not using diagnosis-
related adjunctive therapies during the first six study
months, the average Disease and Symptom Score
improvements were increased by 10% and 6%, respec-
tively [25]. Albeit it is a single-arm therapy study with all
it's limitations, the study enrolled a large number of
patients, had a high follow up period and high follow up
rates, and can be regarded as a qualitatively well per-
formed study which addressed several other relevant bias
factors [9,25].
Taken together, one may suggest that EYT could be an rel-
evant contribution of AM in the treatment of diseases par-
ticularly with (psycho-)neurological movement affections
[31]. This unique intervention might be an interesting
treatment option in conventional health care system, and
thus should be investigated also in a non-anthroposophi-
cal context, but with trained therapists. For the patients,
there is no need to agree with the views of AM, but they
are advised to follow the external movements of EYT with
guided imagery. A recent study on the physiological
effects of EYT showed that EYT with internal "movement"
was performed much slower than the sole movement
without guided imaginary, and thus effects on heart rate
variability were more pronounced in the first group
(Cysarz et al., in preparation).
Conclusion
Although indications, study designs, outcome parameters,
and the usage of additional treatments within the identi-
fied studies enrolling EYT were quite heterogeneous, these
studies describe improvements of the symptoms (with rel-
evant effect sizes in most cases; Figure 1), which can be
ascribed to effects of the multimodal treatment
approaches of AM which enrol EYT. EYT could be
regarded as a potentially relevant add-on in a complex
therapeutic concept which intends to support health and
well-being (salutogenesis), although its specific relevance
remains to be clarified. Well performed controlled studies
with defined indications and treatment regimes are highly
recommended.
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